TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

Sherry X. Yang(Target (United States)), James H. Doroshow(National Cancer Institute)
Journal of Hematology & Oncology
May 26, 2021
Cited by 12


Related Papers